Ledger.Open graph →
SEC Form D · filed December 30, 2015

Solstice Biologics LLC

Offering
$4.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robert Adelman · DURHAM, NCDirectorJohn Borgeson · San Jose, CAExecCorey Goodman · San Francisco, CAExec · Director · PromoterCurt Bradshaw · San Francisco, CAExec · Director · PromoterSteven Dowdy · San Fransciso, CADirectorGeorge Rehm · San Francisco, CADirectorJohn Borgeson · San Francisco, CAExecRobert Adelman · South San Francisco, CADirectorCorey Goodman · Suite 595, CAExec · Director · PromoterCurt Bradshaw · San Fransisco, CAExec · Director · PromoterSteven Dowdy · San Francisco, CADirectorGeorge Rehm · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗